{
  "id": "icd11#screening_cues_09ed5a16",
  "title_en": "General — Screening Cues",
  "title_vi": "General — Dấu hiệu sàng lọc",
  "text_en": "disorders | Amnestic disorder 616 Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural or Neurodevelopmental Disorders • Endocrine diseases (e.g. hypothyroidism) • Intracranial injury • Metabolic disorders (e.g. hypo-osmolality or hyponatraemia) • Neoplasms of the brain or central nervous system • Nutritional disorders (e.g. vitamin B or B deficiency) 1 12 6D72.1 Amnestic disorder due to psychoactive substances, including medications Essential (required) features • All diagnostic requirements for amnestic disorder are met. • There is evidence from history, physical examination or laboratory findings that the disturbance is caused by the direct physiological consequences of use of a substance or medication that persists beyond the usual duration of substance intoxication or substance withdrawal. This judgement depends on establishing the following. • The substance or medication and the amount and duration of its use is known to be capable of producing the memory disturbance. • The course of the memory disturbance (e.g. onset, trajectory of symptoms, response to treatment) is consistent with causation by the substance or medication. Note: if the specific substance inducing the amnestic disorder has been identified, it should be classified using the appropriate subcategory: 6D72.10 Amnestic disorder due to use of alcohol 6D72.11 Amnestic disorder due to use of sedatives, hypnotics or anxiolytics 6D72.12 Amnestic disorder due to other specific psychoactive substances, including medications 6D72.13 Amnestic disorder due to use of volatile inhalants. A diagnosis corresponding to the pattern of use of the relevant psychoactive substance (e.g. episode of harmful psychoactive substance use, harmful pattern of psychoactive substance use, substance dependence) may also be assigned. Note: the order of the categories under 6D72.1 Amnestic disorder due to psychoactive substances, including medications, is different from that of other parallel entities (e.g. substance-induced dementia, below), in which the “other specified” category is listed last. This difference is not meaningful; the categories should be used in the same way. 6D72.Y Amnestic disorder, other specified cause Essential (required) features • All diagnostic requirements for amnestic disorder are met. • The amnestic disorder is presumed to be attributable to an identified cause that is not adequately captured by any of the other available amnestic disorder categories. Neurocognitive disorders | Amnestic disorder Neurocognitive disorders | Dementia",
  "gloss_vi": "Disorders | amnestic disorder 616 clinical descriptions and diagnostic requirements for icd-11 mental, behavioural or neurodevelopmental disorders • endocrine diseases (e.g. hypothyroidism) • intracranial injury • metabo...",
  "source": "WHO ICD-11",
  "url": "https://icd.who.int/",
  "lang": "en",
  "axes": {
    "type": [
      "clinical",
      "everyday"
    ],
    "condition": [
      "General"
    ],
    "clinical_section": [
      "screening_cues",
      "management"
    ],
    "life_topics": [
      "study"
    ],
    "advice_section": [],
    "audience": [],
    "risk_band": "low"
  },
  "index_text": "General — Screening Cues General — Dấu hiệu sàng lọc disorders | Amnestic disorder 616 Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural or Neurodevelopmental Disorders • Endocrine diseases (e.g. hypothyroidism) • Intracranial injury • Metabolic disorders (e.g. hypo-osmolality or hyponatraemia) • Neoplasms of the brain or central nervous system • Nutritional disorders (e.g. vitamin B or B deficiency) 1 12 6D72.1 Amnestic disorder due to psychoactive substances, including medications Essential (required) features • All diagnostic requirements for amnestic disorder are met. • There is evidence from history, physical examination or laboratory findings that the disturbance is caused by the direct physiological consequences of use of a substance or medication that persists beyond the usual duration of substance intoxication or substance withdrawal. This judgement depends on establishing the following. • The substance or medication and the amount and duration of its use is known to be capable of producing the memory disturbance. • The course of the memory disturbance (e.g. onset, trajectory of symptoms, response to treatment) is consistent with causation by the substance or medication. Note: if the specific substance inducing the amnestic disorder has been identified, it should be classified using the appropriate subcategory: 6D72.10 Amnestic disorder due to use of alcohol 6D72.11 Amnestic disorder due to use of sedatives, hypnotics or anxiolytics 6D72.12 Amnestic disorder due to other specific psychoactive substances, including medications 6D72.13 Amnestic disorder due to use of volatile inhalants. A diagnosis corresponding to the pattern of use of the relevant psychoactive substance (e.g. episode of harmful psychoactive substance use, harmful pattern of psychoactive substance use, substance dependence) may also be assigned. Note: the order of the categories under 6D72.1 Amnestic disorder due to psychoactive substances, including medications, is different from that of other parallel entities (e.g. substance-induced dementia, below), in which the “other specified” category is listed last. This difference is not meaningful; the categories should be used in the same way. 6D72.Y Amnestic disorder, other specified cause Essential (required) features • All diagnostic requirements for amnestic disorder are met. • The amnestic disorder is presumed to be attributable to an identified cause that is not adequately captured by any of the other available amnestic disorder categories. Neurocognitive disorders | Amnestic disorder Neurocognitive disorders | Dementia Disorders | amnestic disorder 616 clinical descriptions and diagnostic requirements for icd-11 mental, behavioural or neurodevelopmental disorders • endocrine diseases (e.g. hypothyroidism) • intracranial injury • metabo..."
}